Clinical Trials List
2025-06-25 - 2030-03-31
Recruiting3
ICD-10C78.5
Secondary malignant neoplasm of large intestine and rectum
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9197.5
Secondary malignant neoplasm of large intestine and rectum
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- YU-YUN SHAO Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- Been Ren Lin Division of General Surgery
- 郭弘揚 Division of Hematology & Oncology
- 洪基翔 Division of General Surgery
- 呂理駿 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 陳姿君 Division of General Surgery
- Chih-Hung Hsu Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- 陳敬左 Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Liang Chen Division of Colorectal Surgery
- 謝明皓 Division of Colorectal Surgery
- 黃晟瑋 Division of Colorectal Surgery
- 蔡元耀 Division of Colorectal Surgery
- 張伸吉 Division of Colorectal Surgery
- Hwei-Ming Wang Division of Colorectal Surgery
- 陳奕彰 Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
140 participants
